QUEST PHARMATECH INC (QPT.CA) Stock Price & Overview
TSX-V:QPT • CA74836M1068
Current stock price
The current stock price of QPT.CA is 0.03 CAD. Today QPT.CA is down by 0%. In the past month the price decreased by -14.29%. In the past year, price increased by 50%.
QPT.CA Key Statistics
- Market Cap
- 5.074M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- N/A
- Dividend Yield
- N/A
QPT.CA Stock Performance
QPT.CA Stock Chart
QPT.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to QPT.CA. When comparing the yearly performance of all stocks, QPT.CA turns out to be only a medium performer in the overall market: it outperformed 63.54% of all stocks.
QPT.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to QPT.CA. QPT.CA has a bad profitability rating. Also its financial health evaluation is rather negative.
QPT.CA Earnings
QPT.CA Forecast & Estimates
QPT.CA Groups
Sector & Classification
QPT.CA Financial Highlights
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -0.4% | ||
| ROE | -0.42% | ||
| Debt/Equity | 0.04 |
QPT.CA Ownership
QPT.CA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| EPRX | EUPRAXIA PHARMACEUTICALS INC | N/A | 582.994M | ||
| EDT | SPECTRAL MEDICAL INC | N/A | 365.7M | ||
| HBP | HELIX BIOPHARMA CORP | N/A | 126.027M | ||
| MDNA | MEDICENNA THERAPEUTICS CORP | N/A | 58.394M | ||
| COV | COVALON TECHNOLOGIES LTD | 11.86 | 47.23M | ||
| BCT | BRIACELL THERAPEUTICS CORP | N/A | 41.325M | ||
| RVX | RESVERLOGIX CORP | N/A | 34.751M | ||
| MBX | MICROBIX BIOSYSTEMS INC | 3.54 | 34.638M | ||
| HEM | HEMOSTEMIX INC | N/A | 13.668M | ||
| MPH | MEDICURE INC | N/A | 9.918M | ||
| KNE | KANE BIOTECH INC | N/A | 5.448M | ||
| TELO | TELO GENOMICS CORP | N/A | 5.022M |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the TSX Venture Exchange Exchange | Find stocks with similar TA and Setup ratings on the Canadian exchanges | Find stocks with similar Fundamental rating on the Canadian exchanges | Find the competitors with the best technical ratings on the Canadian exchanges | Find the competitors with the best fundamentals on the Canadian exchanges | Find the competitors with the best valuation on the Canadian exchanges | Find the competitors with the best dividend on the Canadian exchanges | Find the competitors with the best analyst ratings on the Canadian exchanges
About QPT.CA
Company Profile
Quest PharmaTech, Inc. is a biotechnology company, which develops and commercializes antibody based immunotherapeutic products for cancer. The company is headquartered in Edmonton, Alberta. The firm is developing products to improve the quality of life. The firm is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The firm has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The firm also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.
Company Info
IPO: 1997-07-23
QUEST PHARMATECH INC
4342 97 Street
Edmonton ALBERTA T6E 6S4 CA
CEO: Ragupathy Madiyalakan,
Employees: 0
Phone: 17804481400
QUEST PHARMATECH INC / QPT.CA FAQ
What does QUEST PHARMATECH INC do?
Quest PharmaTech, Inc. is a biotechnology company, which develops and commercializes antibody based immunotherapeutic products for cancer. The company is headquartered in Edmonton, Alberta. The firm is developing products to improve the quality of life. The firm is also developing a proprietary MAb AR 9.6 targeting truncated MUC16 as theranostic agents for cancer. The firm has a 42.5% ownership interest in OncoQuest Inc. (OncoQuest), a Canadian biotechnology company developing combinatorial immunotherapy products for the treatment of cancer. OncoQuest’s technology platform included a panel of tumor antigen-specific monoclonal antibodies of the immunoglobulin G (IgG) and E (IgE) class targeting CA125, MUC1, PSA, Her2/neu, CA 19.9 and TAG72; and the application of combinatorial immunotherapy to enhance tumor specific immunity and clinical outcome. The firm also has a 23% ownership interest in OncoVent Co., Ltd. (OncoVent), which is developing antibody-based immunotherapeutic products for cancer for the Greater China territory.
Can you provide the latest stock price for QUEST PHARMATECH INC?
The current stock price of QPT.CA is 0.03 CAD.
Does QPT stock pay dividends?
QPT.CA does not pay a dividend.
How is the ChartMill rating for QUEST PHARMATECH INC?
QPT.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Should I buy QPT stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on QPT.CA.